STUDY ON PREVALENCE OF DEPRESSION AND ADVERSE DRUG REACTIONS AMONG SOUTH INDIAN EPILEPTIC PATIENTS
Abstract
Objectives: To compare the prevalence and intensity of adverse drug reactions (ADR) in patients receiving antiepileptic monotherapy and polytherapy,
and to assess the pattern of depression associated with the therapy.
Methods: This is a prospective observational study conducted in neurology outpatient department for a time period of 6 months in a tertiary care
hospital, South India. Patients diagnosed as epileptic for more than 6 months and receiving stable doses of antiepileptic drugs (AED) for 3 months
were included in the study. Study participants receiving monotherapy and polytherapy were divided into groups. A detailed validated questionnaire
was used to assess the incidence and severity of depression and ADRs among the study participants. Mann–Whitney test, Kruskal–Wallis test, and
Wilcoxon signed rank test were used to know the statistical significance at p<0.05.
Results: Among 91 patients with epilepsy, depression was observed mainly in the study group receiving polytherapy than monotherapy. The severity
of ADR observed among various study groups during the first and second visit were compared, which showed that all range of intensity scores were
reported. During the second visit, the severity of ADR was high when compared to the first visit. Further incidence of ADRs with AED therapy was
compared which showed clinically significant values in all ADRs reported in both monotherapy and polytherapy.
Conclusion: Our study showed, maximum ADRs were among the patients receiving polytherapy, and depression was observed in patients receiving
polytherapy. This suggests the need for safe drug practice.
Keywords: Epilepsy, Anti-epileptics, Adverse drug reactions, Depression, Monotherapy, Polytherapy.
Â
Downloads
References
Chang BS, Lowenstein DH. Epilepsy. N Engl J Med
;349(13):1257‑66.
Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D,
et al. Standards for epidemiologic studies and surveillance of epilepsy.
Epilepsia 2011;52 Suppl 7:2‑26.
Schmidt D, Gram L. Monotherapy versus polytherapy in epilepsy. CNS
Drugs 1995;3(3):194‑208.
Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy?
Epilepsia 1981;22(1):1‑10.
Edwards R. Monotherapy with a new generation of anti‑epileptic drugs.
American Epilepsy Society and the American Clinical Neurophysiology
Society Joint Meeting. Pennyslvania, 30
th
Nov‑5
Dec 2001.
Deckers CL. Place of polytherapy in the early treatment of epilepsy.
th
CNS Drugs 2002;16(3):155‑63.
Kanner AM, Balabanov A. Depression and epilepsy: How closely
related are they? Neurology 2002;58:S27‑39.
O’Donoghue MF, Duncan JS, Sander JW. The subjective handicap
of epilepsy. A new approach to measuring treatment outcome. Brain
;121:317‑43.
Schroevers MJ, Sanderman R, van Sonderen E, Ranchor AV. The
evaluation of the center for epidemiologic studies depression (CES‑D)
scale: Depressed and positive affect in cancer patients and healthy
reference subjects. Qual Life Res 2000;9(9):1015‑29.
Salas‑Puig J. Rational anti‑epileptic polytherapy. Drug interactions and
choice of treatment. Rev Neurol 2000;30:886‑9.
Mei PA, Montenegro MA, Guerreiro MM, Guerreiro CA.
Pharmacovigilance in epileptic patients using antiepileptic drugs. Arq
Neuropsiquiatr 2006;64(2A):198‑201.
Shorvon S, Stefan H. Overview of the safety of newer antiepileptic
drugs. Epilepsia 1997;38 Suppl 1:S45‑51.
Despland PA. Current role of novel anti‑epileptics in the treatment of
epilepsies. Schweiz Rundsch Med Prax1996;85 Suppl 4:80‑3.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.